[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335833-105":59,"doc-detail-335833-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","enhancement-of-targeted-therapy-in-combination-with-metformin-on-human-breast-cancer-cell-lines","Enhancement of targeted therapy - in combination with metformin on human breast cancer cell lines","","Breast cancer remains a major global health challenge because of limited treatment options, frequent recurrence, and high morbidity and mortality. The study investigates whether combining metformin, an antidiabetic drug, with targeted therapies can overcome drug resistance in human breast cancer cell lines. Receptor expression was verified and drug concentrations were chosen via cytotoxicity assays, then antitumor effects were evaluated through colony formation, migration, invasion, and tumor and metastatic assessments in CAM models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/enhancement-of-targeted-therapy-in-combination-with-metformin-on-human-breast-cancer-cell-lines/335833/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/enhancement-of-targeted-therapy-in-combination-with-metformin-on-human-breast-cancer-cell-lines/335833.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of combining metformin with targeted therapies in this study?","Question",{"text":112,"@type":113},"To enhance antitumoral effectiveness and potentially address drug resistance by pairing metformin with targeted agents against breast cancer subtypes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which breast cancer cell lines and targeted agents were evaluated?",{"text":117,"@type":113},"Tamoxifen was tested for estrogen receptor-positive cells (MCF-7), trastuzumab for HER2-positive cells (SKBR-3), and antibody against the ROR1 receptor for triple-negative breast cancer cells (MDA-MB-231).",{"name":119,"@type":110,"acceptedAnswer":120},"How were the treatment effects assessed experimentally?",{"text":121,"@type":113},"After confirming relevant receptor expression and selecting drug doses using cytotoxicity assays, effects on colony formation, migration, and invasion were measured in vitro, and tumor area plus metastatic potential were evaluated using ex ovo CAM models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335833,1790150847,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Mahmoudi etal.  \nCell Communication and Signaling (2024) 22:10 [https://doi.org/10.1186/s12964-023-01446-0](https://doi.org/10.1186/s12964-023-01446-0)  \nCell Communication and Signaling  \n RESEARCH Open Access  \nEnhancement of targeted therapy    \nin combination with metformin on human breast cancer cell lines  \nGhazal Mahmoudi 1, Yahya Ehteshaminia2, Parviz Kokhaei3, Seyedeh Farzaneh Jalali4, Farhad Jadidi‑Niaragh5, Abdol Sattar Pagheh6, Seyed Ehsan Enderami7, Saeid Abedian Kenari7 and Hadi Hassannia7,8*  \nAbstract  \nBackground Breast cancer remains a primary global health concern due to its limited treatment options, fre‑ quent disease recurrence, and high rates of morbidity and mortality. Thereby, there is a need for more effective treatment approaches. The proposal suggests that the combination of targeted therapy with other antitumoral agents could potentially address drug resistance. In this study, we examined the antitumoral effect of combining metformin, an antidiabetic drug, with targeted therapies, including tamoxifen for estrogen receptor‑positive (MCF‑ 7), trastuzumab for HER2‑positive (SKBR‑3), and antibody against ROR1 receptor for triple‑negative breast cancer (MDA‑MB‑231) .  \nMethods Once the expression of relevant receptors on each cell line was confirmed and appropriate drug con‑ centrations were selected through cytotoxicity assays, the antitumor effects of both monotherapy and combination therapy on colony formation, migration, invasion were assessed in in vitro as well as tumor area and metastatic poten‑ tial in ex ovo Chick chorioallantoic membrane (CAM) models.  \nResults The results exhibited the enhanced effects of tamoxifen when combined with targeted therapy. This combi‑ nation effectively inhibited cell growth, colony formation, migration, and invasion in vitro. Additionally, it significantly reduced tumor size and metastatic potential in an ex ovo CAM model.  \nConclusions The findings indicate that a favorable strategy to enhance the efficacy of breast cancer treatment would be to combine metformin with targeted therapies.  \nKeywords Breast cancer, Combination therapy, Targeted therapy, Metformin  \n*Correspondence:  \nHadi Hassannia  \n[h.hassannia@mazums.ac.ir](h.hassannia@mazums.ac.ir)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativecom](http://creativecom)‑ [mons.org/publicdomain/zero/1.0/](mons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nMahmoudi etal. Cell Communication and Signaling (2024) 22:10 Page 2 of 13  \nGraphical Abstract  \nIntroduction  \nDespite extensive efforts, breast cancer continues to be a significant cause of morbidity and mortality on a global scale. In 2020, there were an estimated 2.3 million new cases of breast cancer and 680,000 d","cbCairXXqV0eT884","https://ap.wps.com/l/cbCairXXqV0eT884","pdf",7613604,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Breast cancer burden and current treatments\n## Targeted therapy and receptor-defined subtypes\n## Limitations of triple-negative breast cancer therapies","[{\"question\":\"What is the purpose of combining metformin with targeted therapies in this study?\",\"answer\":\"To enhance antitumoral effectiveness and potentially address drug resistance by pairing metformin with targeted agents against breast cancer subtypes.\"},{\"question\":\"Which breast cancer cell lines and targeted agents were evaluated?\",\"answer\":\"Tamoxifen was tested for estrogen receptor-positive cells (MCF-7), trastuzumab for HER2-positive cells (SKBR-3), and antibody against the ROR1 receptor for triple-negative breast cancer cells (MDA-MB-231).\"},{\"question\":\"How were the treatment effects assessed experimentally?\",\"answer\":\"After confirming relevant receptor expression and selecting drug doses using cytotoxicity assays, effects on colony formation, migration, and invasion were measured in vitro, and tumor area plus metastatic potential were evaluated using ex ovo CAM models.\"}]","Enhancement of targeted therapy - in combination with metformin on human breast cancer cell lines | PDF",1790012514,33]